Keyphrases
Prediction Method
100%
Outcome Prediction
100%
18F-FDG PET-CT
100%
Malignant Pleural Mesothelioma
100%
Ipilimumab
100%
Telomerase
100%
Nivolumab
100%
SUVpeak
100%
Metabolic Tumor Volume
60%
Multivariate Analysis
40%
SUVmax
40%
Standardized Uptake Value
40%
Total Lesion Glycolysis
40%
NIPU
40%
Non-associated
20%
Complete Response
20%
Prognostic Value
20%
Early Reduction
20%
Univariate Analysis
20%
Non-responders
20%
Cox Regression
20%
Treatment Response
20%
Partial Response
20%
Distinct Mechanism
20%
Progressive Disease
20%
Solid Tumors
20%
Stable Disease
20%
Response Evaluation Criteria in Solid Tumors (RECIST)
20%
Response Criteria
20%
Survival Outcomes
20%
Objective Response
20%
Wilcoxon Rank Sum Test
20%
Best Overall Response
20%
PET Metrics
20%
Medicine and Dentistry
Positron Emission Tomography-Computed Tomography
100%
Fluorodeoxyglucose F 18
100%
Pleura Mesothelioma
100%
Nivolumab
100%
Prognosis
100%
Telomerase
100%
Immunotherapy
100%
Ipilimumab
100%
Neoplasm
75%
Multivariate Analysis
50%
Proportional Hazards Model
25%
Immunity
25%
Treatment Response
25%
Univariate Analysis
25%
Rank Sum Test
25%
Progressive Disease
25%
Solid Malignant Neoplasm
25%
Polyethylene Terephthalate
25%
Diseases
25%
Pharmacology, Toxicology and Pharmaceutical Science
Immunotherapy
100%
Fluorodeoxyglucose F 18
100%
Pleura Mesothelioma
100%
Prognosis
100%
Nivolumab
100%
Ipilimumab
100%
Telomerase
100%
Polyethylene Terephthalate
100%
Neoplasm
75%
Diseases
50%
Solid Malignant Neoplasm
25%
Immunology and Microbiology
Immunotherapy
100%
Positron Emission Tomography-Computed Tomography
100%
Ipilimumab
100%
Nivolumab
100%
Metabolic Tumor Volume
75%
Immunity
25%